Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease
Clinical trial NCT06986382 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06986382
- Sponsor
- Stanford University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2037-07-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.